Efficacy of Aripiprazole on Cognitive Functions in Parkinson’s Disease: A Systematic Review and Meta-analysis
Objective: To systematically evaluate and quantitatively synthesize evidence on the effect of Aripiprazole on cognitive functions in patients with Parkinson’s disease. Background: Cognitive impairment is…Digital Health, Telemedicine, and Artificial Intelligence in Parkinson’s Disease Management During COVID-19: A Narrative Review
Objective: The objective of this narrative review was to evaluate the effectiveness of telemedicine and AI-based technologies used for the remote monitoring and management of…Electrophysiological Signatures of Peak Tremor Frequency Differentiate Parkinson’s Disease, Essential Tremor, and Dystonic Tremor: A Three-Way Comparative Study
Objective: To define disease-specific tremor frequency and oscillatory signatures across Parkinson’s disease (PD), essential tremor (ET), and dystonic tremor (DT) and assess their diagnostic utility.…Motor and Quality‑of‑Life Outcomes After MR‑Guided Focused Ultrasound Subthalamotomy for Parkinson’s Disease: A Meta‑analysis
Objective: To evaluate the efficacy and safety of MR guided focused ultrasound (MRgFUS) subthalamotomy for improving motor symptoms, medication burden, and quality of life inParkinson’s…Clinical Features and Trajectories Related to Entacapone Use in Parkinson’s Disease: insights from the French NS Park Cohort
Objective: This study aimed to provide real-life entacapone use in French PD expert centers, focusing on temporal trends, therapeutic positioning, and treatment persistence. Background: Optimizing…The Impact of Demographic Factors on Skull Density Ratios in a Hawaii Cohort
Objective: To understand the impact of demographic factors on skull density ratio (SDR) in Hawai‘i patients. Background: SDR is a validated indicator of the ability…Association between Sleep Behaviors and Age at Onset of Parkinson’s Disease
Objective: To investigate the associations between multiple sleep behaviors and the age at onset (AAO) of Parkinson’s disease (PD) using the UK Biobank. Background: Sleep…Do Digital Mobility Outcomes Differ Across Clinically Defined NSD-ISS Stages in Parkinson’s Disease?
Objective: To determine whether digital mobility outcomes (DMOs) differ between individuals with relatively advanced PD grouped according to the clinical criteria of the Neuronal α-Synuclein…Efficacy and Safety of Inhaled and Sublingual Apomorphine for On-Demand Treatment of OFF Episodes in Parkinson’s Disease: A Meta‑Analysis of Randomized Placebo‑Controlled Trials
Objective: To evaluate the efficacy and safety of inhaled (INH) and sublingual (SL) film apomorphine formulations for on-demand treatment of OFF episodes in Parkinson’s disease…Skin Biopsy for Phosphorylated Alpha-Synuclein and DAT Imaging in Patients Diagnosed with Psychogenic Parkinsonism
Objective: Objective:Describe the results of skin biopsy for phosphorylated alpha-synuclein (P-SYN) and dopamine transporter (DAT) imaging in patients previously diagnosed with psychogenic parkinsonism (PP) and…
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 553
- Next Page »